Spain · Delayed Price · Currency is EUR HBX Group International Statistics
Total Valuation
BME:HBX has a market cap or net worth of EUR 1.74 billion. The enterprise value is 2.35 billion.
| Market Cap | 1.74B |
| Enterprise Value | 2.35B |
Important Dates
The last earnings date was Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:HBX has 243.80 million shares outstanding. The number of shares has increased by 31.03% in one year.
| Current Share Class | 243.80M |
| Shares Outstanding | 243.80M |
| Shares Change (YoY) | +31.03% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.74% |
| Owned by Institutions (%) | 41.82% |
| Float | 183.93M |
Valuation Ratios
The trailing PE ratio is 9.46 and the forward PE ratio is 7.37. BME:HBX's PEG ratio is 1.61.
| PE Ratio | 9.46 |
| Forward PE | 7.37 |
| PS Ratio | 2.45 |
| PB Ratio | 2.12 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 4.04 |
| P/OCF Ratio | 4.01 |
| PEG Ratio | 1.61 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.43, with an EV/FCF ratio of 5.47.
| EV / Earnings | 12.66 |
| EV / Sales | 3.32 |
| EV / EBITDA | 6.43 |
| EV / EBIT | 7.22 |
| EV / FCF | 5.47 |
Financial Position
The company has a current ratio of 0.97, with a Debt / Equity ratio of 1.52.
| Current Ratio | 0.97 |
| Quick Ratio | 0.81 |
| Debt / Equity | 1.52 |
| Debt / EBITDA | 3.39 |
| Debt / FCF | 2.90 |
| Interest Coverage | 5.13 |
Financial Efficiency
Return on equity (ROE) is 24.54% and return on invested capital (ROIC) is 18.05%.
| Return on Equity (ROE) | 24.54% |
| Return on Assets (ROA) | 6.27% |
| Return on Invested Capital (ROIC) | 18.05% |
| Return on Capital Employed (ROCE) | 15.49% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 204,140 |
| Profits Per Employee | 53,479 |
| Employee Count | 3,478 |
| Asset Turnover | 0.22 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BME:HBX has paid 49.00 million in taxes.
| Income Tax | 49.00M |
| Effective Tax Rate | 20.94% |
Stock Price Statistics
The stock price has decreased by -28.46% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -28.46% |
| 50-Day Moving Average | 6.60 |
| 200-Day Moving Average | 7.15 |
| Relative Strength Index (RSI) | 64.76 |
| Average Volume (20 Days) | 546,572 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:HBX had revenue of EUR 710.00 million and earned 186.00 million in profits. Earnings per share was 0.75.
| Revenue | 710.00M |
| Gross Profit | 622.00M |
| Operating Income | 328.00M |
| Pretax Income | 234.00M |
| Net Income | 186.00M |
| EBITDA | 368.00M |
| EBIT | 328.00M |
| Earnings Per Share (EPS) | 0.75 |
Balance Sheet
The company has 633.00 million in cash and 1.25 billion in debt, with a net cash position of -616.00 million or -2.53 per share.
| Cash & Cash Equivalents | 633.00M |
| Total Debt | 1.25B |
| Net Cash | -616.00M |
| Net Cash Per Share | -2.53 |
| Equity (Book Value) | 821.00M |
| Book Value Per Share | 3.34 |
| Working Capital | -43.00M |
Cash Flow
In the last 12 months, operating cash flow was 433.00 million and capital expenditures -3.00 million, giving a free cash flow of 430.00 million.
| Operating Cash Flow | 433.00M |
| Capital Expenditures | -3.00M |
| Depreciation & Amortization | 40.00M |
| Net Borrowing | 1.00M |
| Free Cash Flow | 430.00M |
| FCF Per Share | 1.76 |
Margins
Gross margin is 87.61%, with operating and profit margins of 46.20% and 26.20%.
| Gross Margin | 87.61% |
| Operating Margin | 46.20% |
| Pretax Margin | 32.96% |
| Profit Margin | 26.20% |
| EBITDA Margin | 51.83% |
| EBIT Margin | 46.20% |
| FCF Margin | 60.56% |
Dividends & Yields
This stock pays an annual dividend of 0.08, which amounts to a dividend yield of 1.05%.
| Dividend Per Share | 0.08 |
| Dividend Yield | 1.05% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -31.03% |
| Shareholder Yield | -29.94% |
| Earnings Yield | 10.71% |
| FCF Yield | 24.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BME:HBX is 11.59, which is 62.67% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 11.59 |
| Price Target Difference | 62.67% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:HBX has an Altman Z-Score of 0.59 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.59 |
| Piotroski F-Score | 7 |